Sophie Davies: Patients Often Don’t Consider Supplements to Be ‘Medications’
Sophie Davies, Training and Development Supervisor at Bespoke Clinical Services, shared a post on LinkedIn:
“One observation I’ve made during my experience as a clinical pharmacist is that patients often don’t consider supplements to be ‘medications’, so they don’t always mention them during reviews.
During some anticoagulant safety searches, I identified several patients taking omega-3/cod liver oil supplements alongside DOAC therapy.
They were all unaware of the potential additive bleeding risk.
This reinforced how important clear medicine counselling and thorough medication reviews are in reducing preventable harm.
The goal is to translate guidance into practical, usable information to keep patients fully informed.
Small interventions can have a significant impact on patient safety.”
Stay updated with Hemostasis Today.
-
Jun 6, 2026, 16:53Leonardo Roever: Can a Simple Cholesterol Ratio Predict Post-Stroke Depression?
-
Jun 6, 2026, 16:21Abdulkader Jamal Eddin: ABO Blood Group, COVID-19 and Early Respiratory Outcomes in Acute PE
-
Jun 6, 2026, 15:26Yuying Zhang: Grateful to Present on CD44 as A Potential Plasma-Independent Alternative to IVIG in ITP
-
Jun 6, 2026, 15:16Don Deyo: Breakthrough Therapy for Post-Stroke Upper Limb Impairment Now Published
-
Jun 6, 2026, 15:14Julianne Chong: Components of Antithrombotic Stewardship Programs from an International Perspective
-
Jun 6, 2026, 15:13Vincent Ten Cate: The Largest Blood-Based EWAS of Atherosclerosis to Date
-
Jun 6, 2026, 14:58Pearla Awad: Liposomal Iron Is Better Tolerated, With Fewer Adverse Effects and Lower Constipation Rates
-
Jun 6, 2026, 14:48Eliminating DOAC Interference in Routine Coagulation Assays – JTH
-
Jun 6, 2026, 14:30Alan Nurden: Honoring the Legacy of Dr. Richard Aster